Irbesartan Patent Expiration

Irbesartan was first introduced by Sanofi Aventis Us Llc in its drug Avapro on Sep 30, 1997. 23 different companies have introduced drugs containing Irbesartan.


Irbesartan Patents

Given below is the list of patents protecting Irbesartan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Avapro US6342247 Pharmaceutical compositions containing irbesartan Jun 07, 2015

(Expired)

Sanofi Aventis Us
Avapro US6342247

(Pediatric)

Pharmaceutical compositions containing irbesartan Dec 07, 2015

(Expired)

Sanofi Aventis Us


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Irbesartan Generics

Several generic applications have been filed for Irbesartan. The first generic version for Irbesartan was by Teva Pharmaceuticals Usa and was approved on Mar 30, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 22, 2024.

Given below is the list of companies who have filed for Irbesartan generic.


1. APOTEX INC

Apotex Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Discontinued ORAL N/A Oct 15, 2012
150MG tablet Discontinued ORAL N/A Oct 15, 2012
300MG tablet Discontinued ORAL N/A Oct 15, 2012


2. UNICHEM

Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Dec 7, 2015
75MG tablet Prescription ORAL AB Dec 7, 2015
300MG tablet Prescription ORAL AB Dec 7, 2015


3. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Apr 17, 2018
150MG tablet Prescription ORAL AB Apr 17, 2018
300MG tablet Prescription ORAL AB Apr 17, 2018


4. HISUN PHARM HANGZHOU

Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Jun 14, 2016
300MG tablet Prescription ORAL AB Jun 14, 2016
150MG tablet Prescription ORAL AB Jun 14, 2016


5. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB May 22, 2024
150MG tablet Prescription ORAL AB May 22, 2024
300MG tablet Prescription ORAL AB May 22, 2024


6. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Sep 27, 2012
150MG tablet Prescription ORAL AB Sep 27, 2012
300MG tablet Prescription ORAL AB Sep 27, 2012


7. WATSON LABS INC

Watson Laboratories Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Discontinued ORAL N/A Oct 12, 2012
300MG tablet Discontinued ORAL N/A Oct 12, 2012
75MG tablet Discontinued ORAL N/A Oct 12, 2012


8. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Discontinued ORAL N/A Oct 15, 2012
75MG tablet Discontinued ORAL N/A Oct 15, 2012
300MG tablet Discontinued ORAL N/A Oct 15, 2012


9. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Oct 15, 2012
150MG tablet Prescription ORAL AB Oct 15, 2012
300MG tablet Prescription ORAL AB Oct 15, 2012


10. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Discontinued ORAL N/A Sep 27, 2012
150MG tablet Discontinued ORAL N/A Sep 27, 2012
75MG tablet Discontinued ORAL N/A Sep 27, 2012


11. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Prescription ORAL AB Sep 27, 2012
75MG tablet Prescription ORAL AB Sep 27, 2012
150MG tablet Prescription ORAL AB Sep 27, 2012


12. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Oct 15, 2012
150MG tablet Prescription ORAL AB Oct 15, 2012
300MG tablet Prescription ORAL AB Oct 15, 2012


13. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Sep 27, 2012
150MG tablet Prescription ORAL AB Sep 27, 2012
300MG tablet Prescription ORAL AB Sep 27, 2012


14. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Prescription ORAL AB Dec 7, 2015
75MG tablet Prescription ORAL AB Dec 7, 2015
300MG tablet Prescription ORAL AB Dec 7, 2015


15. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Discontinued ORAL N/A Dec 10, 2015
150MG tablet Discontinued ORAL N/A Dec 10, 2015
300MG tablet Discontinued ORAL N/A Dec 10, 2015


16. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Sep 27, 2012
150MG tablet Prescription ORAL AB Sep 27, 2012
300MG tablet Prescription ORAL AB Sep 27, 2012


17. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Prescription ORAL AB Oct 3, 2012
150MG tablet Prescription ORAL AB Oct 3, 2012
75MG tablet Prescription ORAL AB Oct 3, 2012


18. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Discontinued ORAL N/A Sep 27, 2012
75MG tablet Discontinued ORAL N/A Sep 27, 2012
150MG tablet Discontinued ORAL N/A Sep 27, 2012


19. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Prescription ORAL AB Nov 14, 2012
150MG tablet Prescription ORAL AB Nov 14, 2012
75MG tablet Prescription ORAL AB Nov 14, 2012


20. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet Prescription ORAL AB Mar 30, 2012
150MG tablet Prescription ORAL AB Mar 30, 2012
75MG tablet Prescription ORAL AB Mar 30, 2012


21. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Sep 27, 2012
300MG tablet Prescription ORAL AB Sep 27, 2012
150MG tablet Prescription ORAL AB Sep 27, 2012


22. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG tablet Prescription ORAL AB Feb 23, 2015
150MG tablet Prescription ORAL AB Feb 23, 2015
300MG tablet Prescription ORAL AB Feb 23, 2015